| P50 | author | Mark D. Okusa | Q64163926 |
| P2093 | author name string | Hong Ye | |
| | Jacqueline Miller | |
| | Amandeep Bajwa | |
| | Diane L Rosin | |
| | Liping Huang | |
| | Peter I Lobo | |
| | Elvira Kurmaeva | |
| | Joseph C Gigliotti | |
| P2860 | cites work | Regulatory myeloid cells in transplantation | Q26999875 |
| | Regulatory dendritic cell therapy: from rodents to clinical application | Q27025996 |
| | Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses | Q28210836 |
| | Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation | Q28588671 |
| | Identification of a receptor required for the anti-inflammatory activity of IVIG. | Q37018736 |
| | Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions | Q37187014 |
| | Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance | Q37659828 |
| | Development of dendritic cell-based immunotherapy for autoimmunity | Q37701864 |
| | Moving to tolerance: clinical application of T regulatory cells | Q37881151 |
| | Cytokines in acute kidney injury (AKI). | Q37925881 |
| | CD169+ macrophages at the crossroads of antigen presentation | Q37970844 |
| | Dendritic cell vaccination in autoimmune disease | Q38078202 |
| | Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. | Q38187110 |
| | Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation | Q39488891 |
| | Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation | Q40763807 |
| | Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses | Q44521235 |
| | Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney | Q44916450 |
| | Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials | Q44974183 |
| | Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury | Q46503010 |
| | Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells | Q46620099 |
| | Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. | Q46859827 |
| | Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. | Q50541519 |
| | Long-term prevention of chronic allograft rejection by regulatory T-cell immunotherapy involves host Foxp3-expressing T cells. | Q51072024 |
| | Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm. | Q53563325 |
| | Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. | Q53874628 |
| | Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration | Q57779785 |
| | Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells | Q73289620 |
| | High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor | Q80284338 |
| | Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration | Q28592508 |
| | Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor | Q28595009 |
| | Immunobiology of dendritic cells | Q29547465 |
| | An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 |
| | Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway | Q30411026 |
| | Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection | Q30417431 |
| | Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury | Q30423015 |
| | Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury | Q30423883 |
| | Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury | Q30432124 |
| | Macrophages, dendritic cells, and kidney ischemia-reperfusion injury | Q30432565 |
| | Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney | Q30434337 |
| | Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury | Q30435312 |
| | IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury | Q30437432 |
| | Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury | Q30439331 |
| | The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury | Q30439547 |
| | Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease | Q30440476 |
| | NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury | Q30443445 |
| | CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes | Q30496134 |
| | The location of splenic NKT cells favours their rapid activation by blood-borne antigen | Q30514281 |
| | Functions of a new family of sphingosine-1-phosphate receptors | Q31640177 |
| | CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. | Q33246091 |
| | Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates | Q33804736 |
| | Sphingosine 1-phosphate, a key cell signaling molecule | Q34128454 |
| | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics | Q34144161 |
| | Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation | Q34282217 |
| | The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities | Q34662025 |
| | Vascular-resident CD169-positive monocytes and macrophages control neutrophil accumulation in the kidney with ischemia-reperfusion injury | Q35228562 |
| | Cellular pathophysiology of ischemic acute kidney injury | Q35484725 |
| | Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice | Q35698980 |
| | Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury | Q35715879 |
| | Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs | Q36002657 |
| | Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure | Q36169286 |
| | Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network | Q36184401 |
| | Ischemia-reperfusion and immediate T cell responses | Q36973884 |
| P433 | issue | 4 | |
| P921 | main subject | dendritic cell | Q506253 |
| | reperfusion injury | Q1413991 |
| P304 | page(s) | 1076-1090 | |
| P577 | publication date | 2015-08-18 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury | |
| P478 | volume | 27 | |